skip to main content
Idioma:
Refinado por: assunto: Biological And Medical Sciences remover data de publicação: Após 2011 remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis
Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis

Merchante, Nicolás ; Rivero-Juárez, Antonio ; Téllez, Francisco ; Merino, Dolores ; José Ríos-Villegas, Maria ; Márquez-Solero, Manuel ; Omar, Mohamed ; Macías, Juan ; Camacho, Ángela ; Pérez-Pérez, Montserrat ; Gómez-Mateos, Jesús ; Rivero, Antonio ; Antonio Pineda, Juan

Hepatology (Baltimore, Md.), 2012-07, Vol.56 (1), p.228-238 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
2
Genomic analysis of high-risk smoldering multiple myeloma
Genomic analysis of high-risk smoldering multiple myeloma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Genomic analysis of high-risk smoldering multiple myeloma

LOPEZ-CORRAL, Lucía ; VICTORIA MATEOS, María ; CORCHETE, Luis A ; EUGENIA SARASQUETE, Maria ; DE LA RUBIA, Javier ; DE ARRIBA, Felipe ; LAHUERTA, Juan-José ; GARCIA-SANZ, Ramon ; SAN MIGUEL, Jesus F ; GUTIERREZ, Norma C

Haematologica (Roma), 2012-09, Vol.97 (9), p.1439-1443 [Periódico revisado por pares]

Pavia: Ferrata Storti Foundation

Texto completo disponível

Citações Citado por
3
Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis
Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis

van Vollenhoven, Ronald F ; Fleischmann, Roy ; Cohen, Stanley ; Lee, Eun Bong ; García Meijide, Juan A ; Wagner, Sylke ; Forejtova, Sarka ; Zwillich, Samuel H ; Gruben, David ; Koncz, Tamas ; Wallenstein, Gene V ; Krishnaswami, Sriram ; Bradley, John D ; Wilkinson, Bethanie

The New England journal of medicine, 2012-08, Vol.367 (6), p.508-519 [Periódico revisado por pares]

Waltham, MA: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
4
Myelodysplasia-associated immunophenotypic alterations of bone marrow cells in myeloma: are they present at diagnosis or are they induced by lenalidomide?
Myelodysplasia-associated immunophenotypic alterations of bone marrow cells in myeloma: are they present at diagnosis or are they induced by lenalidomide?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Myelodysplasia-associated immunophenotypic alterations of bone marrow cells in myeloma: are they present at diagnosis or are they induced by lenalidomide?

MATARRAZ, Sergio ; PAIVA, Bruno ; DIEZ-CAMPELO, María ; CORRAL, Lucia-López ; PEREZ, Estefanfa ; MATEOS, Maria-Victoria ; GIRALDO, Pilar ; HERNANDEZ, Miguel T ; SAN MIGUEL, Jesús F ; ORTHO, Alberto

Haematologica (Roma), 2012-10, Vol.97 (10), p.1608-1616 [Periódico revisado por pares]

Pavia: Ferrata Storti Foundation

Texto completo disponível

Citações Citado por
5
Long-Term Benefit of Early Pre-Reperfusion Metoprolol Administration in Patients With Acute Myocardial Infarction: Results From the METOCARD-CNIC Trial (Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction)
Long-Term Benefit of Early Pre-Reperfusion Metoprolol Administration in Patients With Acute Myocardial Infarction: Results From the METOCARD-CNIC Trial (Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Long-Term Benefit of Early Pre-Reperfusion Metoprolol Administration in Patients With Acute Myocardial Infarction: Results From the METOCARD-CNIC Trial (Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction)

PIZARRO, Gonzalo ; FERNANDEZ-FRIERA, Leticia ; DE MIGUEL, Antonio ; GARCIA-LUNAR, Inés ; PARRA-FUERTES, Juan J ; SANCHEZ-GONZALEZ, Javier ; PARDILLOS, Luis ; NIETO, Beatriz ; JIMENEZ, Adriana ; ABEJON, Raquel ; BASTANTE, Teresa ; DE VEGA, Vicente Martínez ; FUSTER, Valentin ; CABRERA, José A ; LOPEZ-MELGAR, Beatriz ; GUZMAN, Gabriela ; GARCIA-PRIETO, Jaime ; MIRELIS, Jesús G ; ZAMORANO, José Luis ; ALBARRAN, Agustín ; GOICOLEA, Javier ; ESCANED, Javier ; POCOCK, Stuart ; FERNANDEZ-JIMENEZ, Rodrigo ; INIGUEZ, Andrés ; FERNANDEZ-ORTIZ, Antonio ; SANCHEZ-BRUNETE, Vicente ; MACAYA, Carlos ; IBANEZ, Borja ; GARCIA-RUIZ, José M ; GARCIA-ALVAREZ, Ana ; MATEOS, Alonso ; BARREIRO, Maria V ; ESCALERA, Noemí ; RODRIGUEZ, Maite D

Journal of the American College of Cardiology, 2014-06, Vol.63 (22), p.2356-2362 [Periódico revisado por pares]

New York, NY: Elsevier

Texto completo disponível

Citações Citado por
6
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

KUMAR, S. K ; LEE, J. H ; LELEU, X ; HULIN, C ; KLEIN, S. K ; SONNEVELD, P ; SIEGEL, D ; BLADE, J ; GOLDSCHMIDT, H ; JAGANNATH, S ; MIGUEL, J. S ; ORLOWSKI, R ; LAHUERTA, J. J ; PALUMBO, A ; SEZER, O ; RAJKUMAR, S. V ; DURIE, Bgm ; MORGAN, G ; RICHARDSON, P. G ; CROWLEY, J ; HAESSLER, J ; FEATHER, J ; HOERING, A ; MOREAU, P

Leukemia, 2012-01, Vol.26 (1), p.149-157 [Periódico revisado por pares]

Avenel, NJ: Nature Publishing Group

Texto completo disponível

Citações Citado por
7
Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir
Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir
Material Type:
Artigo 		Adicionar ao Meu Espaço

Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir

MARTINEZ, Esteban ; D'ALBUQUERQUE, Polyana M ; PICH, Judit ; GATELL, José M ; LLIBRE, Josep M ; GUTIERREZ, Felix ; PODZAMCZER, Daniel ; ANTELA, Antonio ; BERENGUER, Juan ; DOMINGO, Pere ; MORENO, Xabier ; PEREZ, Ignacio

AIDS (London), 2012-11, Vol.26 (18), p.2315-2326 [Periódico revisado por pares]

Hagerstown, MD: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
8
Placebo effect characteristics observed in a single, international, longitudinal study in Huntington's disease
Placebo effect characteristics observed in a single, international, longitudinal study in Huntington's disease
Material Type:
Artigo 		Adicionar ao Meu Espaço

Placebo effect characteristics observed in a single, international, longitudinal study in Huntington's disease

Cubo, Esther ; González, Miguel ; del Puerto, Inés ; de Yébenes, Justo Garcia ; Arconada, Olga Fernández ; Gabriel y Galán, José María Trejo

Movement disorders, 2012-03, Vol.27 (3), p.439-442 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.